Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

267 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethanes--new biological response modifiers for the therapy of breast cancer. Synthesis and evaluation of estrogenic/antiestrogenic properties.
Schertl S, Hartmann RW, Batzl-Hartmann C, Schlemmer R, Spruss T, Bernhardt G, Gust R, Schönenberger H. Schertl S, et al. Among authors: gust r. Arch Pharm (Weinheim). 2001 Apr;334(4):125-37. doi: 10.1002/1521-4184(200104)334:4<125::aid-ardp125>3.0.co;2-d. Arch Pharm (Weinheim). 2001. PMID: 11382148
[1,2-Bis(2-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a new compound for the therapy of ovarian cancer. II. Synthesis and preliminary testing of the enantiomeric complexes.
Bernhardt G, Gust R, Reile H, vom Orde HD, Müller R, Keller C, Spruss T, Schönenberger H, Burgemeister T, Mannschreck A, et al. Bernhardt G, et al. Among authors: gust r. J Cancer Res Clin Oncol. 1992;118(3):201-8. doi: 10.1007/BF01410135. J Cancer Res Clin Oncol. 1992. PMID: 1548285
[1,2-Bis(2-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a new compound for the therapy of ovarian cancer. III. Detailed evaluation of the antitumor activity of the enantiomeric complexes on the human NIH:OVCAR-3 ovarian cancer cell line.
Bernhardt G, Gust R, Reile H, vom Orde HD, Müller R, Keller C, Spruss T, Schönenberger H, Burgemeister T, Mannschreck A, et al. Bernhardt G, et al. Among authors: gust r. J Cancer Res Clin Oncol. 1992;118(3):209-15. doi: 10.1007/BF01410136. J Cancer Res Clin Oncol. 1992. PMID: 1548286
Tumor-inhibiting [1,2-bis(fluorophenyl)ethylenediamine]platinum(II) complexes. V. Synthesis and evaluation of enantiomeric [1,2-bis-(4-fluorophenyl)ethylenediamine]dichloroplatinum(II) complexes.
vom Orde HD, Reile H, Müller R, Gust R, Bernhardt G, Spruss T, Schönenberger H, Burgemeister T, Mannschreck A. vom Orde HD, et al. Among authors: gust r. J Cancer Res Clin Oncol. 1990;116(5):434-8. doi: 10.1007/BF01612989. J Cancer Res Clin Oncol. 1990. PMID: 2229132
Platinum compounds with estrogen receptor affinity.
Bednarski PJ, Gust R, Spruss T, Knebel N, Otto A, Farbel M, Koop R, Holler E, von Angerer E, Schönenberger H. Bednarski PJ, et al. Among authors: gust r. Cancer Treat Rev. 1990 Sep;17(2-3):221-31. doi: 10.1016/0305-7372(90)90052-h. Cancer Treat Rev. 1990. PMID: 2272037 Review. No abstract available.
267 results